ebomi
Colour theme
Sign in
Insider · CIK 0001283290

Lim Jonathan E

CIK 0001283290 Name as filed on the most recent filing

Filed as Lim Jonathan E (21)· LIM Jonathan E (1)

222 transaction lines · from 22 filings · filed 2004-08-18 to 2023-12-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

222 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-12-06 Erasca, Inc.
ERAS 		P, Open-market purchase 278,150 acquired 1.72 478,418.00 Form 4, filing 0001209191-23-057681
2023-12-05 Erasca, Inc.
ERAS 		P, Open-market purchase 721,850 acquired 1.69 1,217,760.95 Form 4, filing 0001209191-23-057681
2023-10-05 Erasca, Inc.
ERAS 		P, Open-market purchase 1,000,000 acquired 2.03 2,026,000.00 Form 4, filing 0001209191-23-052403
2023-06-08 Erasca, Inc.
ERAS 		P, Open-market purchase 100,000 acquired 2.75 275,000.00 Form 4, filing 0001209191-23-035590
2023-03-28 Erasca, Inc.
ERAS 		P, Open-market purchase 100,000 acquired 2.84 284,000.00 Form 4, filing 0001209191-23-021458
2023-01-10 Erasca, Inc.
ERAS 		P, Open-market purchase 60,000 acquired 3.86 231,420.00 Form 4, filing 0001209191-23-002802
2022-12-14 Erasca, Inc.
ERAS 		P, Open-market purchase 40,000 acquired 4.99 199,600.00 Form 4, filing 0001209191-22-061352
2016-03-17 Ignyta, Inc.
RXDX 		P, Open-market purchase 24,852 acquired 5.51 136,879.85 Form 4, filing 0001209191-16-109694
2015-08-20 Ignyta, Inc.
RXDX 		P, Open-market purchase 1,700 acquired 12.69 21,572.83 Form 4, filing 0001209191-15-067373
2015-08-20 Ignyta, Inc.
RXDX 		P, Open-market purchase 40 acquired 12.77 510.69 Form 4, filing 0001209191-15-067373
2015-08-19 Ignyta, Inc.
RXDX 		P, Open-market purchase 6,500 acquired 12.95 84,186.70 Form 4, filing 0001209191-15-067373
2015-08-19 Ignyta, Inc.
RXDX 		P, Open-market purchase 240 acquired 13.05 3,132.00 Form 4, filing 0001209191-15-067373
2015-03-20 Ignyta, Inc.
RXDX 		P, Open-market purchase 20,000 acquired 9.01 180,200.00 Form 4, filing 0001209191-15-028872
2014-08-15 Ignyta, Inc.
RXDX 		P, Open-market purchase 5,000 acquired 7.60 37,997.00 Form 4, filing 0001209191-14-053585
2008-03-20 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 250,000 disposed 6.06 1,515,000.00 Form 4, filing 0001418145-08-000022
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 5,100 disposed 8.25 42,075.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 3,360 disposed 8.21 27,585.60 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 2,568 disposed 8.31 21,340.08 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 2,132 disposed 8.30 17,695.60 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,600 disposed 8.23 13,168.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,440 disposed 8.20 11,808.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,200 disposed 8.18 9,816.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 800 disposed 8.16 6,528.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 602 disposed 8.17 4,918.34 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 400 disposed 8.27 3,308.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 300 disposed 8.26 2,478.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 298 disposed 8.19 2,440.62 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 100 disposed 8.29 829.00 Form 4, filing 0001418145-07-000008
2007-11-30 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 100 disposed 8.06 806.00 Form 4, filing 0001418145-07-000008
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 12,700 disposed 9.03 114,681.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 4,700 disposed 9.04 42,488.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 4,700 disposed 9.02 42,394.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,090 disposed 9.06 9,875.40 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 710 disposed 9.05 6,425.50 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 400 disposed 9.01 3,604.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 300 disposed 9.15 2,745.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 300 disposed 9.07 2,721.00 Form 4, filing 0001380444-07-000064
2007-10-31 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 100 disposed 9.16 916.00 Form 4, filing 0001380444-07-000064
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 3,500 disposed 8.71 30,485.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 3,010 disposed 8.80 26,488.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,880 disposed 8.83 16,600.40 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,610 disposed 8.81 14,184.10 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,500 disposed 8.75 13,125.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,350 disposed 8.76 11,826.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,299 disposed 8.89 11,548.11 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 1,100 disposed 8.82 9,702.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 950 disposed 8.72 8,284.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 900 disposed 8.79 7,911.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 700 disposed 8.92 6,244.00 Form 4, filing 0001380444-07-000050
2007-09-28 Halozyme Therapeutics Inc
HALO 		S, Open-market sale 700 disposed 8.88 6,216.00 Form 4, filing 0001380444-07-000050

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 15
  • Open-market sale 207
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Lim Jonathan E, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001283290

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.